Latest / Pricing Power Podcast with Fexingo: How Businesses Set Prices, Raise Margins, and Win Customers
How EpiPen Pricing Sparked a Backlash That Changed Pharma
In 2016, Mylan raised the price of EpiPen from $100 to $600, igniting public outrage and congressional hearings. This episode unpacks the specific decisions that led to that price hike — from the patent strategy that blocked competition to the rebate trap that insulated Mylan from normal market pressure. Lucas and Luna walk through the per-unit economics: how a two-dollar device became a six-hundred-dollar necessity. They also explore the aftermath: the rise of authorized generics, the FTC investigations, and whether anything actually changed for patients. A focused case study on how extreme…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.